Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.28180
Abstract: Long noncoding RNA (lncRNA) AGAP2 antisense RNA 1 (AGAP2‐AS1) has been suggested to function as an oncogenic lncRNA in lung cancer, breast cancer, and anaplastic glioma. However, the expression pattern and molecular mechanism of AGAP2‐AS1…
read more here.
Keywords:
agap2;
oncogenic lncrna;
glioblastoma multiforme;
agap2 as1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Bioscience Reports"
DOI: 10.1042/bsr20191202
Abstract: Long noncoding RNAs (LncRNAs) refer to the RNA with a length of >200 nucleotides, which lack or have no open reading coding frame and have higher tissue and organ specificity compared with the protein coding…
read more here.
Keywords:
human malignancies;
oncogenic lncrna;
vital oncogenic;
novel vital ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Cell Proliferation"
DOI: 10.1111/cpr.12513
Abstract: Long noncoding RNAs (lncRNAs) are a class of noncoding, endogenous, single‐stranded RNAs longer than 200 nucleotides in length that are transcribed by RNA polymerase II. Mounting evidence has indicated that lncRNAs play key roles in…
read more here.
Keywords:
novel vital;
zfas1 novel;
oncogenic lncrna;
vital oncogenic ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Non-Coding RNA"
DOI: 10.3390/ncrna9010002
Abstract: Traditionally, small molecule-based drug discovery has mainly focused on proteins as the drug target. Opening RNA as an additional target space for small molecules offers the possibility to therapeutically modulate disease-driving non-coding RNA targets as…
read more here.
Keywords:
lncrna malat1;
oncogenic lncrna;
small molecules;
molecules modulate ... See more keywords